Scarica l'app Stockscreener
2.68
1.47%
-0.04
Pre-mercato:
2.63
-0.05
-1.87%
Precedente Chiudi:
$2.72
Aprire:
$2.67
Volume 24 ore:
1.10M
Relative Volume:
4.43
Capitalizzazione di mercato:
$80.29M
Reddito:
-
Utile/perdita netta:
$-75.52M
Rapporto P/E:
-0.9306
EPS:
-2.88
Flusso di cassa netto:
$-56.92M
1 W Prestazione:
-2.55%
1M Prestazione:
+6.77%
6M Prestazione:
+26.42%
1 anno Prestazione:
-87.58%
Intervallo 1D:
$2.57
$2.69
Intervallo di 1 settimana:
$2.57
$2.86
Portata 52W:
$1.25
$25.29
Aerovate Therapeutics Inc Stock (AVTE) Company Profile
Nome
Aerovate Therapeutics Inc
Settore
Industria
Telefono
617-443-2400
Indirizzo
930 WINTER STREET, WALTHAM
Confronta AVTE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVTE
Aerovate Therapeutics Inc
|
2.68 | 80.29M | 0 | -75.52M | -56.92M | -2.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
493.84 | 122.76B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
602.64 | 61.38B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
614.76 | 36.37B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
251.56 | 30.12B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
244.90 | 24.70B | 3.81B | -644.79M | -669.77M | -6.24 |
Aerovate Therapeutics Inc Stock (AVTE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-18 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Downgrade | TD Cowen | Buy → Hold |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-06-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-03-25 | Ripresa | Jefferies | Buy |
| 2023-12-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-12-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-08-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-02-11 | Iniziato | BTIG Research | Buy |
| 2021-07-26 | Iniziato | Cowen | Outperform |
| 2021-07-26 | Iniziato | Evercore ISI | Outperform |
| 2021-07-26 | Iniziato | Jefferies | Buy |
| 2021-07-26 | Iniziato | Wedbush | Outperform |
Mostra tutto
Aerovate Therapeutics Inc Borsa (AVTE) Ultime notizie
Russell Investments Group Ltd. Boosts Stake in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
Aerovate Therapeutics, Inc. SEC 10-Q Report - TradingView
Aerovate Therapeutics Inc (AVTE) Performance and Fundamentals Dashboard tells a completely different story - Sete News
AVTE’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
Aerovate Therapeutics Presents Phase 1 Data for AV-101, A Novel Dry Powder Inhaled Formulation of Imatinib Being Developed for the Treatment of Patients with Pulmonary Arterial Hypertension (PAH) - Barchart.com
AVTE Shares Experience Decline in Value - knoxdaily.com
Aerovate approves reverse split ahead of Jade merger By Investing.com - Investing.com South Africa
Aerovate Therapeutics and Jade Biosciences Merger Approved - citybiz
Aerovate Stockholders Approve Merger Proposal With Jade Biosciences - Nasdaq
Aerovate approves reverse split ahead of Jade merger - Investing.com
Aerovate (AVTE) Stockholders Approve Merger with Jade Biosciences | AVTE Stock News - GuruFocus
Aerovate Therapeutics Approves Merger with Jade Biosciences - TipRanks
Aerovate Therapeutics stockholders approve proposed merger with Jade Biosciences - TipRanks
Aerovate Therapeutics Stockholders Approve Proposed Merger With Jade Biosciences And All Related Proposals - marketscreener.com
Aerovate Therapeutics Stockholders Approve Proposed Merger with Jade Biosciences and All Related Proposals - PR Newswire
Aerovate announces $69.6 million special dividend By Investing.com - Investing.com India
Aerovate announces $69.6 million special dividend - Investing.com Australia
Aerovate Therapeutics Declares Special Cash Dividend In Connection With The Proposed Merger With Jade Biosciences - marketscreener.com
Aerovate Therapeutics Declares Special Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PR Newswire
Aerovate signals cash dividend ahead of Jade merger By Investing.com - Investing.com South Africa
Aerovate Therapeutics Stock Bucks Broader Market Sell-Off Over Dividend Announcement: Stock Rises But Retail’s Unmoved - NewsBreak: Local News & Alerts
Aerovate Therapeutics Announces Range Of Expected Cash Dividend - MarketScreener
Aerovate Therapeutics Announces Merger with Jade Biosciences - TipRanks
Aerovate signals cash dividend ahead of Jade merger - Investing.com
Aerovate Therapeutics Announces Range of Expected Cash Dividend in Connection with the Proposed Merger with Jade Biosciences - PR Newswire
36,897 Shares in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Acquired by Corient Private Wealth LLC - Defense World
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of AMPY, HEES, AVTE, TGI to Act - The Malaysian Reserve
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, AV - GuruFocus
$HAREHOLDER ALERT: The M&A Class Action Firm Urges Stockholders of AMPY, HEES, AVTE, TGI to Act Now - GlobeNewswire Inc.
Aerovate Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Aerovate Therapeutics Inc. (AVTE) reports earnings - Quartz
Aerovate Therapeutics Inc expected to post a loss of 25 cents a shareEarnings Preview - TradingView
AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc.AVTE - Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AMPS, PTMN, AVTE on Behalf of Shareholders - The Malaysian Reserve
Aerovate Therapeutics (AVTE) Expected to Announce Quarterly Earnings on Monday - Defense World
FY2029 Earnings Estimate for AVTE Issued By Wedbush - MarketBeat
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, BMTX, PFIE, ALTR on Behalf of Shareholders - ACCESS Newswire
FY2029 Earnings Forecast for AVTE Issued By Wedbush - Defense World
In Another Blow to Delaware's Hegemony Another Company Proposes Reincorporation in Nevada - NatLawReview.com
$HAREHOLDER ALERT: The M&A Class Action Firm Continues To Investigate The MergerCCNE, LGTY, AVTE, PLYA - Longview News-Journal
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, BLUE on Behalf of Shareholders - Stockhouse Publishing
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Increase in Short Interest - MarketBeat
Ready to Jump After Recent Trade: Aerovate Therapeutics Inc (AVTE) - SETE News
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders - EIN News
Deltec Asset Management LLC Invests $514,000 in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - MarketBeat
Aerovate Therapeutics, Inc. (NASDAQ:AVTE) Sees Significant Growth in Short Interest - MarketBeat
Barclays PLC Raises Holdings in Aerovate Therapeutics, Inc. (NASDAQ:AVTE) - Defense World
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MHLD, IPG, AVTE on Behalf of Shareholders - GlobeNewswire
Aerovate Therapeutics Inc Azioni (AVTE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.24%
36.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):